Apoptosis in hepatitis C virus infection
暂无分享,去创建一个
K. Schulze-Osthoff | H. Bantel | K Schulze-Osthoff | H Bantel | Klaus Schulze-Osthoff | Heike Bantel
[1] N Enomoto,et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. , 1996, The New England journal of medicine.
[2] H. Jaeschke,et al. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and fas‐antibody–induced liver injury , 1998, Hepatology.
[3] Y. E. Chin,et al. Stat1 as a Component of Tumor Necrosis Factor Alpha Receptor 1-TRADD Signaling Complex To Inhibit NF-κB Activation , 2000, Molecular and Cellular Biology.
[4] E. Haddad,et al. Caspase dependence of target cell damage induced by cytotoxic lymphocytes. , 1998, Journal of immunology.
[5] S. Nagata,et al. Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes. , 1997, Journal of immunology.
[6] N. Jenkins,et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.
[7] F. Chisari,et al. Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection , 2001, The Journal of experimental medicine.
[8] A. Alberti,et al. Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV‐RNA levels , 2000, Hepatology.
[9] P. Galle,et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage , 1995, The Journal of experimental medicine.
[10] M. Lenzi,et al. Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. , 1996, Blood.
[11] F. Chisari. Cytotoxic T cells and viral hepatitis. , 1997, The Journal of clinical investigation.
[12] M. Leist,et al. Concanavalin A - induced T-cell - mediated hepatic injury in mice : The role of tumor necrosis factor , 1995 .
[13] O. Schiraldi,et al. Immunoresponsiveness in chronic hepatitis C patients: correlation between tissue and serum findings. , 1998, Immunopharmacology and immunotoxicology.
[14] W K Roth,et al. Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels. , 2000, Journal of hepatology.
[15] M. Raftery,et al. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. , 2001, Immunity.
[16] L. Balart,et al. Chronic hepatitis C with normal aminotransferase levels: a clinical histologic study. , 1997, The American journal of gastroenterology.
[17] M. Kojiro,et al. Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues. , 1996, American Journal of Pathology.
[18] M. Honda,et al. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. , 2002, Gastroenterology.
[19] R. Flavell,et al. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis , 1997, Molecular and cellular biology.
[20] K. Schulze-Osthoff,et al. Detection of elevated caspase activation and early apoptosis in liver diseases. , 2001, European journal of cell biology.
[21] T. Mak,et al. Activation of the dsRNA‐dependent protein kinase, PKR, induces apoptosis through FADD‐mediated death signaling , 1998, The EMBO journal.
[22] M. Chen,et al. Activation of p53 tumor suppressor by hepatitis C virus core protein. , 1999, Virology.
[23] K. Okumura,et al. Type I Interferons (IFNs) Regulate Tumor Necrosis Factor–related Apoptosis-inducing Ligand (TRAIL) Expression on Human T Cells: A Novel Mechanism for the Antitumor Effects of Type I IFNs , 1999, The Journal of experimental medicine.
[24] M. Yanagi,et al. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[25] K. Meyer,et al. Hepatitis C virus NS5A protein protects against TNF-α mediated apoptotic cell death , 2000 .
[26] J F Kerr,et al. Shrinkage necrosis: A distinct mode of cellular death , 1971, The Journal of pathology.
[27] D. Tyrrell,et al. Hepatitis C virus replication in mice with chimeric human livers , 2001, Nature Medicine.
[28] P. Galle,et al. Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion? , 1996, Nature Medicine.
[29] J. Gosálvez,et al. Histological damage in chronic hepatitis C is not related to the extent of infection in the liver. , 1999, The American journal of pathology.
[30] K. Shimotohno,et al. Hepatitis C Virus Core Protein Inhibits Fas- and Tumor Necrosis Factor Alpha-Mediated Apoptosis via NF-κB Activation , 1999, Journal of Virology.
[31] M. Lai,et al. Hepatitis C Virus Core Protein Binds to the Cytoplasmic Domain of Tumor Necrosis Factor (TNF) Receptor 1 and Enhances TNF-Induced Apoptosis , 1998, Journal of Virology.
[32] M. Lenardo,et al. Induction of apoptosis in mature T cells by tumour necrosis factor , 1995, Nature.
[33] O. Yokosuka,et al. HCV-core protein accelerates recovery from the insensitivity of liver cells to Fas-mediated apoptosis induced by an injection of anti-Fas antibody in mice. , 2000, Journal of hepatology.
[34] I. Hewlett,et al. Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: upregulation of trail in primary human macrophages by HIV-1 tat. , 2001, Journal of biomedical science.
[35] S. Fulda,et al. IFNγ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway , 2002, Oncogene.
[36] K. Schulze-Osthoff,et al. Cell nucleus and DNA fragmentation are not required for apoptosis , 1994, The Journal of cell biology.
[37] T. Taniguchi,et al. Antiviral response by natural killer cells through TRAIL gene induction by IFN–α/β , 2001, European journal of immunology.
[38] Y. Yazaki,et al. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection , 1997, Hepatology.
[39] K. Schulze-Osthoff,et al. In situ monitoring of caspase activation in hepatobiliary diseases , 2000, Cell Death and Differentiation.
[40] V. Agnello,et al. Detection of widespread hepatocyte infection in chronic hepatitis C , 1998, Hepatology.
[41] P. Roberts,et al. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. , 2000, Immunity.
[42] Yoshiharu Matsuura,et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice , 1998, Nature Medicine.
[43] R. Francesco. Molecular virology of the hepatitis C virus , 1999 .
[44] M. Alter,et al. Epidemiology of Hepatitis C , 2018, Clinical liver disease.
[45] J. Schmidt,et al. Hepatitis C virus dynamics in vivo: Effect of ribavirin and interferon alfa on viral turnover , 1998, Hepatology.
[46] B. Viollet,et al. Bcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice , 1996, Nature Medicine.
[47] D. Harrison,et al. Alteration in mRNA levels of Fas splice variants in hepatitis C‐infected liver , 1997, The Journal of pathology.
[48] S. Nagata,et al. Lethal effect of the anti-Fas antibody in mice , 1993, Nature.
[49] Y. Shiratori,et al. Activation of intracellular signaling by hepatitis B and C viruses: C‐viral core is the most potent signal inducer , 2000, Hepatology.
[50] Alan S. Perelson,et al. Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy , 1998 .
[51] M. Leist,et al. ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha. , 1997, Immunology letters.
[52] C. Rice,et al. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients , 1996, Journal of virology.
[53] H. Blum,et al. Expression of Hepatitis C Virus Proteins Inhibits Signal Transduction through the Jak-STAT Pathway , 1999, Journal of Virology.
[54] F. Shibasaki,et al. Inhibition of Cytochrome c Release in Fas-mediated Signaling Pathway in Transgenic Mice Induced to Express Hepatitis C Viral Proteins* , 2001, The Journal of Biological Chemistry.
[55] Hoguen Kim,et al. IFN‐γinduces cell death in human hepatoma cells through a trail/death receptor‐mediated apoptotic pathway , 2001, International journal of cancer.
[56] M. Czaja,et al. NF‐κB inhibition sensitizes hepatocytes to TNF‐induced apoptosis through a sustained activation of JNK and c‐Jun , 2002, Hepatology.
[57] David Baltimore,et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB , 1995, Nature.
[58] J. Rakela,et al. Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects. , 2000, Blood.
[59] S. Korsmeyer,et al. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis , 1999, Nature.
[60] M. Lai,et al. Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor. , 2001, Virology.
[61] H. Hotta,et al. Suppression of actinomycin D-induced apoptosis by the NS3 protein of hepatitis C virus. , 1996, Biochemical and biophysical research communications.
[62] J. Peschon,et al. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[63] Zhidong Yao,et al. Hepatitis C Virus Core Protein Inhibits Human T Lymphocyte Responses by a Complement-Dependent Regulatory Pathway1 2 , 2001, The Journal of Immunology.
[64] G. Barber. Host defense, viruses and apoptosis , 2001, Cell Death and Differentiation.
[65] C. Rice,et al. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. , 1997, Science.
[66] Miriam J. Alter. Epidemiology of hepatitis C. , 1996 .
[67] K. Shimotohno,et al. Hepatitis C Virus Core Protein Inhibits Fas-and Tumor Necrosis Factor Alpha-Mediated Apoptosis via NFk B Activation , 1999 .
[68] Dumoulin,et al. Hepatitis C virus core protein does not inhibit apoptosis in human hepatoma cells , 1999, European journal of clinical investigation.
[69] S. Kaneko,et al. Monocyte-dependent cell death of T lymphocyte subsets in chronic hepatitis C. , 2001, Immunology letters.
[70] A. Hughes,et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. , 2001, Immunity.
[71] C. Rice,et al. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. , 1997, Journal of immunology.
[72] N. Hayashi,et al. Serum levels of soluble Fas antigen in chronic hepatitis C patients , 1998, Journal of Hepatology.
[73] L. Owen-Schaub,et al. Activation-Dependent Transcriptional Regulation of the Human fas Promoter Requires NF-κB p50-p65 Recruitment , 1999, Molecular and Cellular Biology.
[74] C. Maliszewski,et al. Monocyte-mediated Tumoricidal Activity via the Tumor Necrosis Factor–related Cytokine, TRAIL , 1999, The Journal of experimental medicine.
[75] K. Okita,et al. Hepatic fas antigen expression before and after interferon therapy in patients with chronic hepatitis C , 1996, Digestive Diseases and Sciences.
[76] V. Barnaba,et al. Dynamics of intra‐hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis , 1998, European journal of immunology.
[77] C. Poremba,et al. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection , 2001, Hepatology.
[78] M. Katze,et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. , 1997, Virology.
[79] C. Tseng,et al. Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions , 2002, The Journal of experimental medicine.
[80] S. Manna,et al. Ectopic Expression of Hepatitis C Virus Core Protein Differentially Regulates Nuclear Transcription Factors , 1998, Journal of Virology.
[81] C. Rauch,et al. Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo , 1999, Nature Medicine.
[82] E. Zarling,et al. Immunohistochemical evaluation of bcl-2 gene family expression in liver of hepatitis C and cirrhotic patients: a novel mechanism to explain the high incidence of hepatocarcinoma in cirrhotics , 1999, American Journal of Gastroenterology.
[83] A. Wendel,et al. Concanavalin A hepatotoxicity in mice: Tumor necrosis factor–mediated organ failure independent of caspase‐3–like protease activation , 1999, Hepatology.
[84] B. Kraupp,et al. In situ detection of fragmented dna (tunel assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note , 1995, Hepatology.
[85] C. Hahn,et al. The HCV core protein acts as a positive regulator of fas-mediated apoptosis in a human lymphoblastoid T cell line. , 2000, Virology.
[86] Aseem Kumar,et al. Defective TNF-α-Induced Apoptosis in STAT1-Null Cells Due to Low Constitutive Levels of Caspases , 1997 .
[87] K. Meyer,et al. Suppression of apoptotic cell death by hepatitis C virus core protein. , 1996, Virology.
[88] V. L. Johnson,et al. Fas‐mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases , 1998, Hepatology.
[89] M. Leist,et al. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. , 1995, The American journal of pathology.
[90] S. S. Strom,et al. Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions , 2001, Nature Medicine.
[91] P. Boya,et al. Nuclear factor‐κB in the liver of patients with chronic hepatitis C: Decreased RelA expression is associated with enhanced fibrosis progression , 2001, Hepatology.
[92] Y. Kohgo,et al. Fas‐mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C , 2000, British journal of haematology.
[93] B. Walker,et al. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. , 1995, The Journal of clinical investigation.
[94] NFκB Mediates Apoptosis through Transcriptional Activation of Fas (CD95) in Adenoviral Hepatitis* , 2000, The Journal of Biological Chemistry.
[95] P. Vandenabeele,et al. Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins. , 1999, Journal of immunology.
[96] D. Baltimore,et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. , 1995, Nature.
[97] K. Meyer,et al. Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity. , 1998, Gene.
[98] Y. Shiratori,et al. Hepatitis C Virus Core Protein Enhances p53 Function through Augmentation of DNA Binding Affinity and Transcriptional Ability* , 2000, The Journal of Biological Chemistry.
[99] S. Strom,et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand , 2000, Nature Medicine.
[100] D. Ferrari,et al. Apoptosis signaling by death receptors. , 1998, European journal of biochemistry.
[101] M. Leist,et al. Concanavalin A—induced T‐cell—mediated hepatic injury in mice: The role of tumor necrosis factor , 1995, Hepatology.
[102] S. Nagata,et al. Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand , 1998, Nature Medicine.
[103] D. Pessayre,et al. Opening of the mitochondrial permeability transition pore causes matrix expansion and outer membrane rupture in fas‐mediated hepatic apoptosis in mice , 2000, Hepatology.
[104] H. Jaeschke,et al. Endotoxin Shock Model Neutrophil-Mediated Necrosis in a Murine Parenchymal Cell Apoptosis and-Induced Hepatic α Is Essential for TNF-Activation of Caspase 3 ( CPP 32 )-Like Proteases , 1998 .
[105] D. Häussinger,et al. Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation. , 1999, Gastroenterology.
[106] R. De Francesco. Molecular virology of the hepatitis C virus. , 1999, Journal of hepatology.
[107] K. Schulze-Osthoff,et al. Role of Reactive Oxygen Intermediates in Activation-induced CD95 (APO-1/Fas) Ligand Expression* , 1998, The Journal of Biological Chemistry.
[108] Frank Scholle,et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. , 2002, Gastroenterology.
[109] G. Bishop,et al. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C , 1996, Hepatology.
[110] S. Kashiwagi,et al. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection , 1997, Hepatology.
[111] N. Hayashi,et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C , 1993, Hepatology.
[112] N. Copeland,et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.
[113] C. Dai,et al. Interferon γ Induces Upregulation and Activation of Caspases 1, 3, and 8 to Produce Apoptosis in Human Erythroid Progenitor Cells , 1999 .
[114] Z. Wang,et al. Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity , 2001, Nature Medicine.
[115] J. Silver,et al. Replication of Subgenomic Hepatitis C Virus Rnas in a Hepatoma Cell Line , 1999 .
[116] M MacFarlane,et al. Different Subcellular Distribution of Caspase-3 and Caspase-7 following Fas-induced Apoptosis in Mouse Liver* , 1998, The Journal of Biological Chemistry.
[117] H. Yagita,et al. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. , 1997, Journal of immunology.
[118] B. Aggarwal,et al. Inhibition of Tumor Necrosis Factor (TNF-α)-mediated Apoptosis by Hepatitis C Virus Core Protein* , 1998, The Journal of Biological Chemistry.
[119] P. Briand,et al. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis , 1996, Current Biology.
[120] M. Honda,et al. Hepatitis C virus core protein induces apoptosis and impairs cell‐cycle regulation in stably transformed chinese hamster ovary cells , 2000, Hepatology.
[121] B. Walker,et al. Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus , 2000, The Journal of experimental medicine.
[122] S. Nagata,et al. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death , 1996, The Journal of experimental medicine.
[123] J. Peschon,et al. IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. , 1999, Journal of immunology.
[124] M. Peter,et al. Cleavage of FLICE (caspase‐8) by granzyme B during cytotoxic T lymphocyte‐induced apoptosis , 1997, European journal of immunology.
[125] K. Okita,et al. Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver , 1999, Hepatology.
[126] E. Zuckerman,et al. Enhanced peripheral T-cell apoptosis in chronic hepatitis C virus infection: association with liver disease severity. , 2001, Journal of hepatology.
[127] Y. Liaw,et al. Activation of nuclear factor κB in hepatitis C virus infection: Implications for pathogenesis and hepatocarcinogenesis , 2000, Hepatology.
[128] J. Maher,et al. Anti-Fas Induces Hepatic Chemokines and Promotes Inflammation by an NF-κB-independent, Caspase-3-dependent Pathway* , 2001, The Journal of Biological Chemistry.
[129] P. Möller,et al. TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections. , 2002, Gastroenterology.
[130] G. Ostapowicz,et al. Fas‐mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection , 2001, Journal of viral hepatitis.
[131] Y. Matsuura,et al. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. , 1997, Virology.
[132] N. Hayashi,et al. Role of Fas ligand in apoptosis induced by hepatitis C virus infection. , 1994, Biochemical and biophysical research communications.
[133] K. Tokushige,et al. Significance of soluble TNF receptor-I in acute-type fulminant hepatitis , 2000, American Journal of Gastroenterology.